FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/11/2024
Voltar para busca
Dado oficial do USPTO
RECEPTKINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
23/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
12/01/2023
Data de registro
07/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/05/2024
Última transação
07/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
MCMORROW, JANICE
Unidade examinadora
M60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ILDONG PHARMACEUTICAL CO., LTD.
Representantes
Kwang Yup Chae Hauptman Ham, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-pharmaceutical preparations for use in the treatment of cancerimmune system related diseases and disorders; Albuminous preparations for medical purposes; Drugs for medical purposesfor use in the treatment of cancerimmune system related diseases and disorders; Colostral antibodies for medical purposes; Antibody reagents for medical purposes for use in the treatment of cancer; Blood for medical purposes; Enzymes for medical purposes; Pharmaceutical drugs for use in the treatment of cancerimmune system related diseases and disorders; Human immune globulin; Medicines for human purposesfor use in the treatment of cancerimmune system related diseases and disorders; Human plasma protein being blood plasma; Pharmaceutical preparations for use in the treatment of cancerimmune system related diseases and disorders; Haematogenblood substitutes for human use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antivirals; Antigens for use in the treatment of cancer; Antibody reagents used for the detection of the antigens in cells and tissue for medical purposes; Pharmaceutical preparations for use in hematology
Classe 42
Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Drug discovery services; Development of pharmaceutical preparations and medicines; Testinginspection and research services in the fields of pharmaceuticalscosmetics and foodstuffs; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Laboratory research services relating to pharmaceuticals; Medical and pharmacological research services; Medical research; Medical and pharmacological researchclinical trials for others; Blood analysis services for scientific research purposes; Chemical engineering
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/11/2024
FIMP
FINAL DISPOSITION PROCESSED
04/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
27/02/2024
PUBO
PUBLISHED FOR OPPOSITION
20/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/01/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/01/2024
RFNT
REFUSAL PROCESSED BY IB
13/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/10/2023
RFRR
REFUSAL PROCESSED BY MPU
24/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/10/2023
CNRT
NON-FINAL ACTION WRITTEN
11/10/2023
DOCK
ASSIGNED TO EXAMINER
10/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
15/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RECEPTKINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.